Zacks Investment Research on MSN19h
TSVT Up on Acquisition Agreement With BMY for $286 MillionShares of 2seventy bio, Inc. TSVT gained 5.26% after the company announced a definitive merger agreement with Bristol Myers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback